Click here to get this information.
0 Special Issues
Affect This Company
Discovers, develops, manufactures and commercializes biotherapeutics for unmet medical needs
The Swiss pharmaceutical conglomerate Hoffmann-La Roche now completely owns Genentech after completing its purchase on 26 March 2009 for approximately $46.8 billion.
1 DNA Way
© 2008-2017 CSRHub
Want to learn more about CSRHub?